Gene 'Signature' and Lung Cancer Jamaica Plain MA

In a finding that could lead to a simple blood test to screen for lung cancer, U.S. researchers have identified immune system markers that indicate early-stage lung tumors in people at high risk for lung cancer.

Therese M Mulvey, MD
(617) 479-3550
10 Willard St
Quincy, MA
Business
Commonwealth Physicians Services Inc
Specialties
Oncology

Data Provided by:
Margaret J Lawler, MD
(617) 983-7777
1153 Centre St
Jamaica Plain, MA
Gender
Female
Education
Medical School: Mc Master Univ, Sch Of Med, Hamilton, Ont, Canada
Graduation Year: 1984
Hospital
Hospital: Faulkner Hosp, Boston, Ma
Group Practice: Faulkner Breast Ctr

Data Provided by:
Stephen Arthur Landaw, MD
781-235-3065 x221
241 Perkins St Unit C105
Jamaica Plain, MA
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: George Washington Univ Sch Of Med & Hlth Sci, Washington Dc 20037
Graduation Year: 1959

Data Provided by:
Margaret Mary Duggan
(617) 983-7777
1153 Centre St
Boston, MA
Specialty
General Surgery, Surgical Oncology

Data Provided by:
Geoffrey K Sherwoo, MR
(617) 983-7160
1153 Centre St
Boston, MA
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Sreela Ghoshroy, MBBS
617-232-9500 x5544
150 S Huntington Ave
Jamaica Plain, MA
Specialties
Internal Medicine, Hematology-Oncology
Gender
Male
Education
Medical School: Univ Of Calcutta, Med Coll, Calcutta, We
Graduation Year: 1982

Data Provided by:
Geoffrey Kray Sherwood
(617) 983-7160
1153 Centre St
Boston, MA
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Faina Nakhlis
(617) 983-7777
1153 Centre St
Boston, MA
Specialty
Surgical Oncology

Data Provided by:
Mary Therese Brophy
(617) 232-9500
150 S Huntington Ave
Boston, MA
Specialty
Hematology / Oncology

Data Provided by:
Ante Sven Lundberg
(617) 232-9500
150 S Huntington Ave
Boston, MA
Specialty
Medical Oncology

Data Provided by:
Data Provided by:

Gene 'Signature' and Lung Cancer

Provided By:

TUESDAY, Dec. 1 (HealthDay News) -- In a finding that could lead to a simple blood test to screen for lung cancer, U.S. researchers have identified immune system markers that indicate early-stage lung tumors in people at high risk for lung cancer.

The researchers examined gene expression profiles in blood samples from 137 people with non-small cell lung cancer and a control group of 91 people with non-malignant lung diseases, such as chronic obstructive pulmonary disease, emphysema or benign lung nodules.

They identified a 29-gene "signature" that was 86 percent accurate in identifying those with lung cancer, who had certain genetic changes in immune cells that the others did not.

Blood samples were taken from 18 of those with lung cancer before surgery to remove their tumors and two to five months after surgery. After surgery, 13 of them showed a decrease or disappearance of the tumor gene signature.

The study was published online Dec. 1 in Cancer Research.

The researchers said it might be possible to use the findings to develop a simple blood test to screen for lung cancer.

"People routinely get blood taken at their doctors' offices for cholesterol levels, diabetes and other standard tests, so why not utilize this method to screen for other conditions such as the risk of developing lung cancer?" Louise C. Showe, a professor in the molecular and cellular oncology and immunology programs and director of the genomics facility at the Wistar Institute in Philadelphia, said in a news release from the institute.

"Such a test could be especially useful for remote areas where, typically, technologies that are used in urban centers are not available," she said. "In addition, this test could be useful in a clinical setting to help to decide whether a small tumor detected on an X-ray is likely to be malignant."

More information

The U.S. National Cancer Institute has more about lung cancer screening.

SOURCE: Wistar Institute, news release, Dec. 1, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com